NEW YORK (
CHANGE IN RATINGS, EPS
upgraded to buy at TheStreet ratings.
upgraded at Wells from Market Perform to Outperform. Company is guiding toward better near-term growth.
target raised at Goldman to $53. Positive earnings call commentary. Maintain Buy rating.
price target raised at Goldman to $28. Costs saves a modest plus, but expect muted PM-USA profit in 2012. Neutral rating.
downgraded at UBS from Buy to Neutral. $20 price target. Major concerns about ability to execute and two SEC investigations.
estimates raised at Goldman through 2011 following through this quarter's upside. Maintain $47 price target and Buy rating.
Bristol Myers Squibb
target raised at UBS.BMY price target increased to $32. Launches still key, growth continues. Neutral rating.
estimates, target reduced at Credit Suisse. BG estimates were cut through 2012. Agribusiness profits will likely be lower than expected. Outperform rating and new $72 price target.
estimates, target reduced at Credit Suisse.Shares of CAM now seen reaching $71. Estimates also cut, as the company is seeing slower growth in North America. Outperform rating.
estimates, target boosted at Credit Suisse.Shares of CERN now seen reaching $67. Higher sales are driving margin growth. Neutral rating.
rated new Buy at Deutsche.KO was initiated with a Buy rating. $75 price target. Growth potential remains highest in the emerging markets.
downgraded at Wells from Outperform to Market Perform. Admission rates have been hurt by Tenet's allegations.
downgraded at Jefferies from Hold to Underperform. $51 price target. Competitors are more attractive ways to play this sector.
numbers raised at Credit Suisse.Shares of DECK now seen reaching $122. Estimates also increased, as Ugg continues to drive growth. Outperform rating.
estimates, target cut at Credit Suisse.DOW estimates were cut through 2012. Company is seeing lower demand across the board. Outperform rating and new $40 price target.
Dow Chemical estimates lowered at UBS through 2012. Third quarter was in line, but rough patch is coming. Maintain $38 price target and Buy rating.
downgraded at BMO from Outperform to Market Perform. $37 price target. Better opportunities to play this sector.
downgraded at Credit Suisse from Outperform to Neutral. $67 price target. Company lacks near-term catalysts.
estimates, target cut at Credit Suisse.Shares of EXPE now seen reaching $35. Estimates also reduced, given slower air growth. Neutral rating.
estimates lowered at Credit Suisse through 2014. Company is seeing lower volumes and paying a higher tax rate. Neutral rating and $95 price target.
ExxonMobil estimates increased at UBS through 2012. 3Q EPS in line. Maintain $90 price target and Buy rating.
downgraded at Benchmark from Buy to Hold. $115 price target. Valuation call.
estimates, target cut at Credit Suisse. Shares of HSY now seen reaching $68. Estimates also reduced, as the company continues to spend more on advertising. Outperform rating.
downgraded at Jefferies from Buy to Hold. $55 price target. Company has limited upside earnings potential.
numbers raised at Goldman Sachs.Shares of MAT now seen reaching $31. Estimates also increased as investor day highlights soldi trajectory. Neutral rating.
( MDTH) downgraded to sell at TheStreet ratings.
downgraded at Morgan Stanley to Underweight. $12 price target. Estimates also cut, given increased execution risk.
upgraded at Credit Suisse from Neutral to Outperform. $135 price target. Volumes are growing in North America.
Occidental Petroleum estimates raised at UBS through 2012. Strong 3Q on stronger than expected production. Maintain $112 price target and Buy rating.
downgraded at Jefferies from Buy to Hold. $56 price target. Current price reflects full value.
downgraded at Wells from Outperform to Market Perform. Valuation call. Chlorine demand remains weak.
rated new Buy at Deutsche Bank. $70 price target. Company offers growth at a reasonable price.
downgraded at JP Morgan from Overweight to Neutral. $7.50 price target. New products are not producing expected growth.
estimates, target increased at Goldman.Shares of POT now seen reaching $61. Estimates also increased to reflect an improved nitrogen and phosphate outlook. Buy rating.
downgraded at BMO from Outperform to Market Perform. $10 price target. See no near term developments to suggest fundamentals are strengthening.
downgraded at UBS from Neutral to Buy. $125 price target. Catalysts have played out as expected.
rated new Outperform at Credit Suisse. Company continues to recruit new customers in a difficult business environment. $35 price target.
numbers lowered at UBS. Shares of HOT now seen reaching $67. Estimates also lowered as macro uncertainties still prevail. Buy rating.
downgraded at Keybanc from Buy to Hold. Valuation call.
Time Warner Cable
estimates, target lowered at UBS.Shares of TWC now seen reaching $80. Estimates also lowered as voice goes negative and HSD weaker than expected. Buy rating.
Time Warner Cable
downgraded at Wells to Market Perform. Estimates also cut. Stock could be range-bound, following a disappointing quarter.
added to Top Picks List at FBR Capital Markets. Company has strong secular trends heading into 2012. Outperform rating and $120 price target.
upgraded at Credit Suisse from Underperform to Neutral. $72 price target. Company can continue to deliver growth through smaller markets.
Readers Also Like:
This article was written by a staff member of TheStreet.